Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia
…, M Ichikawa, A Shiraki, Y Goto, Y Fukui… - American journal of …, 2013 - atsjournals.org
Rationale: Identification of patients with drug-resistant pathogens at initial diagnosis is
essential for treatment of pneumonia. Objectives: To elucidate clinical features of community-…
essential for treatment of pneumonia. Objectives: To elucidate clinical features of community-…
[HTML][HTML] Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients
…, M Kaneda, A Ueno, Y Miyajima, K Kawago, Y Fukui… - PloS one, 2020 - journals.plos.org
Objective To investigate the relationship between viral load and secondary transmission in
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …
SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19
…, K Kimoto, A Ueno, Y Miyajima, Y Fukui… - Journal of Medical …, 2022 - Wiley Online Library
This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study
…, M Ando, M Ichikawa, Y Goto, Y Fukui… - The Lancet Infectious …, 2015 - thelancet.com
Background Appropriate initial antibiotics are essential for the treatment of infectious
diseases. However, some patients with pneumonia might develop adverse outcomes, despite …
diseases. However, some patients with pneumonia might develop adverse outcomes, despite …
[HTML][HTML] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
…, T Suzuki, H Kawasuji, A Ueno, Y Miyajima, Y Fukui… - Virology journal, 2021 - Springer
Background SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is now
classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly …
classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly …
Waon therapy improves quality of life as well as cardiac function and exercise capacity in patients with chronic heart failure
M Sobajima, T Nozawa, Y Fukui, H Ihori… - International heart …, 2015 - jstage.jst.go.jp
Waon therapy (WT), which in Japanese means soothing warmth, is a repeated sauna
therapy that improves cardiac and vascular endothelial function in patients with chronic heart …
therapy that improves cardiac and vascular endothelial function in patients with chronic heart …
[HTML][HTML] Circulating type I interferon levels in the early phase of COVID-19 are associated with the development of respiratory failure
…, M Kaneda, A Ueno, Y Miyajima, Y Fukui… - Frontiers in …, 2022 - frontiersin.org
Background The role of type I interferons (IFNs) in the early phase of COVID-19 remains
unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID-19 …
unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID-19 …
Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of …
…, Y Murai, A Ueno, Y Miyajima, Y Fukui… - Microbiology …, 2021 - Am Soc Microbiol
Serological tests are beneficial for recognizing the immune response against severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity, …
respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity, …
Age-dependent reduction in neutralization against alpha and beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity
…, Y Murai, A Ueno, Y Miyajima, Y Fukui… - Microbiology …, 2021 - Am Soc Microbiol
Vaccines against severe acute respiratory syndrome coronavirus-2 have been introduced.
To investigate the relationship between vaccine-induced humoral immunity and patient age, …
To investigate the relationship between vaccine-induced humoral immunity and patient age, …
[HTML][HTML] Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19
…, K Kimoto, A Ueno, Y Miyajima, K Kawago, Y Fukui… - Scientific Reports, 2021 - nature.com
Adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …